|
|
|
Insider
Information: |
Hoberman Kenneth |
Relationship: |
Director |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
297,825 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$3,858,692 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
297,825 |
|
|
Total
Value |
$3,858,692 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
5
|
Stock
price went up :
|
0
|
5
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
5.0
|
Percentage
Gain/Loss : |
0.0%
|
402.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Stemline Therapeutics Inc |
STML |
Chief Operating Officer |
2020-06-10 |
0 |
|
0 |
Premium* |
|
TG Therapeutics Inc |
TGTX |
Director |
2023-09-28 |
242,685 |
|
0 |
Premium* |
|
Nuvectis Pharma, Inc. |
NVCT |
Director |
2022-05-12 |
55,140 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
|
2020-06-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,374,352) |
0 |
0 |
- |
|
STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
|
2020-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
600,000 |
1,374,352 |
0 |
- |
|
STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
|
2018-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
275,000 |
686,034 |
0 |
- |
|
STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
|
2020-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
208,417 |
809,502 |
0 |
- |
|
STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
|
2016-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
212,562 |
0 |
- |
|
STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
|
2019-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
148,678 |
795,330 |
0 |
- |
|
STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
|
2017-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
131,469 |
409,143 |
0 |
- |
|
STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
|
2016-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
87,985 |
299,044 |
0 |
- |
|
STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
|
2018-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
70,303 |
439,581 |
0 |
- |
|
STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
|
2015-12-31 |
4 |
GD |
$0.00 |
$0 |
D/D |
60,000 |
62,119 |
0 |
- |
|
TGTX |
TG Therapeutics Inc |
Director |
|
2022-07-20 |
4 |
A |
$0.00 |
$0 |
D/D |
43,732 |
222,685 |
0 |
- |
|
STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
|
2013-11-25 |
4 |
OE |
$1.11 |
$41,070 |
D/D |
37,000 |
79,765 |
0 |
- |
|
STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
|
2013-11-22 |
4 |
OE |
$1.11 |
$38,850 |
D/D |
35,000 |
54,288 |
0 |
- |
|
STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
|
2013-11-27 |
4 |
OE |
$1.11 |
$37,710 |
D/D |
33,973 |
103,211 |
0 |
- |
|
STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
|
2015-03-19 |
4 |
OE |
$4.09 |
$110,859 |
D/D |
27,105 |
139,426 |
0 |
- |
|
TGTX |
TG Therapeutics Inc |
|
|
2019-09-17 |
4 |
A |
$0.00 |
$0 |
D/D |
27,048 |
143,953 |
0 |
- |
|
STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
|
2018-11-26 |
4 |
S |
$11.85 |
$311,608 |
D/D |
(26,296) |
659,738 |
0 |
- |
|
STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
|
2019-05-14 |
4 |
S |
$14.27 |
$368,409 |
D/D |
(25,817) |
729,879 |
0 |
- |
|
STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
|
2019-06-25 |
4 |
S |
$15.07 |
$384,285 |
D/D |
(25,500) |
695,272 |
0 |
- |
|
STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
|
2019-03-11 |
4 |
S |
$11.11 |
$278,872 |
D/D |
(25,101) |
756,677 |
0 |
- |
|
STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
|
2019-12-24 |
4 |
S |
$10.97 |
$268,513 |
D/D |
(24,477) |
653,968 |
0 |
- |
|
STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
|
2015-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
24,379 |
112,321 |
0 |
- |
|
STML |
Stemline Therapeutics Inc |
Chief Operating Officer |
|
2020-01-22 |
4 |
S |
$7.02 |
$155,416 |
D/D |
(22,139) |
601,085 |
0 |
% |
|
TGTX |
TG Therapeutics Inc |
Director |
|
2021-06-18 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
178,953 |
0 |
- |
|
TGTX |
TG Therapeutics Inc |
Director |
|
2023-09-28 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
242,685 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|